Evolus Ownership | Who Owns Evolus?


OverviewForecastRevenueFinancialsChartTranscripts

Evolus Ownership Summary


Evolus is owned by 74.94% institutional investors, 14.64% insiders, and 10.42% retail investors. Nantahala capital management is the largest institutional shareholder, holding 8.59% of EOLS shares. BioPharma Credit Ord is the top mutual fund, with 8.78% of its assets in Evolus shares.

EOLS Ownership Benchmark


TypeName% Inst% Insiders% Retail
StockEvolus74.94%14.64%10.42%
SectorHealthcare Stocks 244.59%12.11%-156.70%
IndustrySpecialty & Generic Drug Manufacturers Stocks37.12%13.99%48.89%

Institutional Shareholders


Top Institutional Shareholders by Total Shares

HolderShares% HoldingValue
Nantahala capital management5.60M8.59%$38.88M
Blackrock funding, inc. /de4.84M7.43%$33.60M
Blackrock4.01M6.82%$43.49M
Caligan partners lp4.14M6.41%$25.41M
Vanguard group3.34M5.16%$22.22M
Braidwell lp3.16M4.84%$21.90M
Frazier life sciences management2.63M4.04%$18.26M
Perceptive advisors2.46M3.77%$17.07M
Vanguard capital management2.36M3.62%$16.40M
Millennium management1.79M2.74%$12.41M

Top Institutional Shareholders by % of Total Assets

HolderShares% AssetsValue
Allostery investments lp60.00K7.04%$552.60K
Stonepine capital management1.59M5.17%$11.04M
Caligan partners lp4.14M3.33%$25.41M
Awh capital625.00K3.04%$4.34M
Soviero asset management, lp770.00K2.25%$5.34M
Altium capital management lp685.00K2.15%$7.56M
Cm management400.00K1.76%$2.78M
Nantahala capital management5.60M1.29%$38.88M
Braidwell lp3.16M0.81%$21.90M
Potomac capital management141.50K0.67%$982.01K

Top Buyers

HolderShares% AssetsChange
Point72 asset management1.51M0.01%1.51M
Perceptive advisors2.46M0.26%1.17M
Caligan partners lp4.14M3.33%796.97K
Blackrock4.01M0.00%747.40K
Blackrock funding, inc. /de4.84M0.00%550.45K

Top Sellers

HolderShares% AssetsChange
Soleus capital management822.43K0.20%-1.42M
Frontier capital management270.51K0.01%-1.39M
Tri locum partners lp---1.24M
Soros fund management---995.49K
Schroder investment management group---986.47K

New Positions

HolderShares% AssetsChangeValue
Point72 asset management1.51M0.01%1.51M$10.47M
Sixth street partners management company530.84K0.00%530.84K$3.68M
Prospect capital advisors208.10K0.66%208.10K$1.28M
Angeles wealth management105.55K0.03%105.55K$732.48K
Centerbook partners lp91.74K0.03%91.74K$636.68K

Sold Out

HolderChange
Hughes financial services-1.00
National bank of canada /fi/-2.00
Coldstream capital management-12.00
Lindbrook capital-21.00
Assetmark-30.00

Institutional Ownership Trends


DateHoldingsChange %SharesChange %OwnershipChange %Increased PositionChange %Decreased PositionChange %
Jun 30, 20261667.79%48,851,4006.99%741.49%895.95%39-9.30%
Mar 31, 2026150-13.29%45,445,549-7.67%701.22%82-11.83%41-16.33%
Dec 31, 202594-43.37%19,539,863-64.07%300.42%54-32.50%21-61.11%
Sep 30, 202571-60.77%16,258,044-72.12%250.31%35-61.96%19-62.75%
Jun 30, 2025180-1.64%58,292,2378.05%901.26%915.81%51-15.00%

Top Mutual Funds Shareholders


HolderShares% HoldingChange
BioPharma Credit Ord5.66M8.78%-99.14K
Vanguard US Total Market Shares ETF1.68M2.65%-
Vanguard Total Stock Mkt Idx Inv1.54M2.35%-120.90K
Vanguard Morn Total Stk Mkt Idx Investor1.54M2.35%-120.90K
Vanguard MStar Total Stk Mkt Idx Invest1.54M2.34%-
iShares Russell 2000 ETF1.50M2.28%-26.69K
Vanguard Institutional Extnd Mkt Idx Tr771.73K1.17%1.71K
Schroder US Smaller Companies Acc718.22K1.11%-15.14K
Oberweis Micro-Cap Growth677.60K1.05%-
Oberweis Micro-Cap677.60K1.05%-

Recent Insider Transactions


DateNameRoleActivityValue
Sep 02, 2026MOATAZEDI DAVID See RemarksSell$950.02K
Mar 20, 2026Avelar Rui See RemarksSell$14.82K
Mar 20, 2026MOATAZEDI DAVID See RemarksSell$64.93K
Mar 17, 2026MOATAZEDI DAVID See RemarksSell$570.56K
Mar 17, 2026Avelar Rui See RemarksSell$146.63K

Insider Transactions Trends


DateBuySell
2026 Q3-1
2026 Q1-4
2025 Q4-2
2025 Q311
2025 Q215

EOLS Ownership FAQ


Who Owns Evolus?

Evolus shareholders are primarily institutional investors at 74.94%, followed by 14.64% insiders and 10.42% retail investors. The average institutional ownership in Evolus's industry, Specialty & Generic Drug Manufacturers Stocks, is 37.12%, which Evolus exceeds.

Who owns the most shares of Evolus?

Evolus’s largest shareholders are Nantahala capital management (5.6M shares, 8.59%), Blackrock funding, inc. /de (4.84M shares, 7.43%), and Blackrock (4.01M shares, 6.82%). Together, they hold 22.84% of Evolus’s total shares outstanding.

Does Blackrock own Evolus?

Yes, BlackRock owns 6.82% of Evolus, totaling 4.01M shares as of Jun 2024. This represents 0.00% of BlackRock's total assets, with a market value of 43.49M$. In the last quarter, BlackRock increased its holdings by 747.4K shares, a 22.92% change.

Who is Evolus’s biggest shareholder by percentage of total assets invested?

Allostery investments lp is Evolus’s biggest shareholder by percentage of total assets invested, with 7.04% of its assets in 60K Evolus shares, valued at 552.6K$.

Who is the top mutual fund holder of Evolus shares?

BioPharma Credit Ord is the top mutual fund holder of Evolus shares, with 8.78% of its total shares outstanding invested in 5.66M Evolus shares.

Try Tickergate Pro Free

Customize Everything. 100% Flexibility. Fast and Easy to Use (No code or Excel Needed)

  • Customize your own personal stocks lists, views and charts

  • Choose from hundreds of fields, up to 15 years of history

  • Conduct deep comparison analysis

  • Discover trending investment themes

  • Find your next best investment

  • Research stocks using tools